PDB Short entry for 2HC0 HEADER HYDROLASE 14-JUN-06 2HC0 TITLE STRUCTURE OF HIV PROTEASE 6X MUTANT IN COMPLEX WITH AB-2. COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 500-598; COMPND 5 EC: 3.4.23.16; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 STRAIN: NL4-3; SOURCE 5 GENE: GAG-POL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21.DE3, PLYS S; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET 21A+ KEYWDS HIV, PROTEASE, MUTANT, ASPARTYL, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR H.HEASLET,A.BRIK,Y.-C.LIN,J.H.ELDER,C.D.STOUT REVDAT 4 20-OCT-21 2HC0 1 REMARK SEQADV LINK REVDAT 3 13-JUL-11 2HC0 1 VERSN REVDAT 2 24-FEB-09 2HC0 1 VERSN REVDAT 1 26-JUN-07 2HC0 0 JRNL AUTH H.HEASLET,A.BRIK,Y.-C.LIN,J.H.ELDER,C.D.STOUT JRNL TITL STRUCTURE OF HIV PROTEASE 6X MUTANT IN COMPLEX WITH AB-2 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELX REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 87.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.161 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.194 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.168 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1137 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 23580 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : NULL REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1510 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 59 REMARK 3 SOLVENT ATOMS : 293 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : NULL REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : NULL REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : NULL REMARK 3 NUMBER OF RESTRAINTS : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 ANGLE DISTANCES (A) : NULL REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : NULL REMARK 3 ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : NULL REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL REMARK 3 SIMILAR ADP COMPONENTS (A**2) : NULL REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2HC0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-JUN-06. REMARK 100 THE DEPOSITION ID IS D_1000038178. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-APR-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : RIGAKU VARIMAX HF CONFOCAL REMARK 200 MIRROR REMARK 200 OPTICS : RIGAKU VARIMAX HF CONFOCAL REMARK 200 MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 92 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTALCLEAR REMARK 200 DATA SCALING SOFTWARE : D*TREK 9.4SSI REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32061 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.300 REMARK 200 RESOLUTION RANGE LOW (A) : 61.240 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.7 REMARK 200 DATA REDUNDANCY : 1.670 REMARK 200 R MERGE (I) : 0.03900 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.35 REMARK 200 COMPLETENESS FOR SHELL (%) : 74.1 REMARK 200 DATA REDUNDANCY IN SHELL : 1.30 REMARK 200 R MERGE FOR SHELL (I) : 0.43800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.08 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.93 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M NA ACETATE, 3.5 NABR, PH 4.6, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 281.16K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+3/4 REMARK 290 4555 Y,-X,Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 16.83000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 25.24500 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 8.41500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 6450 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9360 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A1008 NE - CZ - NH2 ANGL. DEV. = 4.6 DEGREES REMARK 500 ASP A1030 CB - CG - OD2 ANGL. DEV. = -7.2 DEGREES REMARK 500 ARG A1041 NE - CZ - NH1 ANGL. DEV. = 4.4 DEGREES REMARK 500 ARG A1041 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 ARG A1057 NE - CZ - NH2 ANGL. DEV. = 3.5 DEGREES REMARK 500 ARG A1087 NE - CZ - NH1 ANGL. DEV. = 3.9 DEGREES REMARK 500 ARG A1087 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 ARG B2108 NE - CZ - NH2 ANGL. DEV. = -3.2 DEGREES REMARK 500 LYS B2114 CB - CG - CD ANGL. DEV. = 20.2 DEGREES REMARK 500 ARG B2141 NE - CZ - NH2 ANGL. DEV. = -3.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A1079 89.15 -69.05 REMARK 500 GLU B2135 124.94 -36.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BR A 4001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BR B 4002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BR B 4003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BR B 4004 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BR B 4005 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BR A 4006 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BR A 4007 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BR B 4008 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BR B 4009 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BR A 4011 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BR A 4012 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AB2 A 3500 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ZP8 RELATED DB: PDB REMARK 900 STRUCTURE OF HIV PROTEASE WILD-TYPE IN COMPLEX WITH AB-2 REMARK 900 RELATED ID: 2HB2 RELATED DB: PDB REMARK 900 RELATED ID: 2HB4 RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 MUTATIONS AT POSITIONS 1024,1046,1053,1063,1077,1082 REMARK 999 CHAIN A AND 2124,2146,2153,2163,2177,2182 CHAIN B REMARK 999 ARE RESULTS OF DRUG RESISTANCE SELECTION. REMARK 999 THE GLN1007/2107LYS MUTATIONS WERE ADDED TO PREVENT REMARK 999 AUTOPROTEOLYSIS. DBREF 2HC0 A 1001 1099 UNP P03367 POL_HV1BR 500 598 DBREF 2HC0 B 2101 2199 UNP P03367 POL_HV1BR 500 598 SEQADV 2HC0 LYS A 1007 UNP P03367 GLN 506 ENGINEERED MUTATION SEQADV 2HC0 ILE A 1024 UNP P03367 LEU 523 ENGINEERED MUTATION SEQADV 2HC0 ILE A 1046 UNP P03367 MET 545 ENGINEERED MUTATION SEQADV 2HC0 LEU A 1053 UNP P03367 PHE 552 ENGINEERED MUTATION SEQADV 2HC0 PRO A 1063 UNP P03367 LEU 562 ENGINEERED MUTATION SEQADV 2HC0 ILE A 1077 UNP P03367 VAL 576 ENGINEERED MUTATION SEQADV 2HC0 ALA A 1082 UNP P03367 VAL 581 ENGINEERED MUTATION SEQADV 2HC0 LYS B 2107 UNP P03367 GLN 506 ENGINEERED MUTATION SEQADV 2HC0 ILE B 2124 UNP P03367 LEU 523 ENGINEERED MUTATION SEQADV 2HC0 ILE B 2146 UNP P03367 MET 545 ENGINEERED MUTATION SEQADV 2HC0 LEU B 2153 UNP P03367 PHE 552 ENGINEERED MUTATION SEQADV 2HC0 PRO B 2163 UNP P03367 LEU 562 ENGINEERED MUTATION SEQADV 2HC0 ILE B 2177 UNP P03367 VAL 576 ENGINEERED MUTATION SEQADV 2HC0 ALA B 2182 UNP P03367 VAL 581 ENGINEERED MUTATION SEQRES 1 A 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 A 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU ILE ASP THR SEQRES 3 A 99 GLY ALA ASP ASP THR VAL LEU GLU GLU MET ASN LEU PRO SEQRES 4 A 99 GLY ARG TRP LYS PRO LYS ILE ILE GLY GLY ILE GLY GLY SEQRES 5 A 99 LEU ILE LYS VAL ARG GLN TYR ASP GLN ILE PRO ILE GLU SEQRES 6 A 99 ILE CYS GLY HIS LYS ALA ILE GLY THR VAL LEU ILE GLY SEQRES 7 A 99 PRO THR PRO ALA ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 A 99 GLN ILE GLY CYS THR LEU ASN PHE SEQRES 1 B 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 B 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU ILE ASP THR SEQRES 3 B 99 GLY ALA ASP ASP THR VAL LEU GLU GLU MET ASN LEU PRO SEQRES 4 B 99 GLY ARG TRP LYS PRO LYS ILE ILE GLY GLY ILE GLY GLY SEQRES 5 B 99 LEU ILE LYS VAL ARG GLN TYR ASP GLN ILE PRO ILE GLU SEQRES 6 B 99 ILE CYS GLY HIS LYS ALA ILE GLY THR VAL LEU ILE GLY SEQRES 7 B 99 PRO THR PRO ALA ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 B 99 GLN ILE GLY CYS THR LEU ASN PHE HET BR A4001 1 HET BR A4006 1 HET BR A4007 1 HET BR A4011 2 HET BR A4012 2 HET AB2 A3500 94 HET BR B4002 1 HET BR B4003 1 HET BR B4004 1 HET BR B4005 1 HET BR B4008 1 HET BR B4009 1 HET BR B4010 1 HETNAM BR BROMIDE ION HETNAM AB2 [1-((1S,2R)-1-BENZYL-2-HYDROXY-3-{ISOBUTYL[(4- HETNAM 2 AB2 METHOXYPHENYL)SULFONYL]AMINO}PROPYL)-1H-1,2,3-TRIAZOL- HETNAM 3 AB2 4-YL]METHYL (1R,2R)-2-HYDROXY-2,3-DIHYDRO-1H-INDEN-1- HETNAM 4 AB2 YLCARBAMATE FORMUL 3 BR 12(BR 1-) FORMUL 8 AB2 C34 H41 N5 O7 S FORMUL 16 HOH *293(H2 O) HELIX 1 1 GLY A 1086 THR A 1091 1 6 HELIX 2 2 GLN A 1092 GLY A 1094 5 3 HELIX 3 3 GLY B 2186 THR B 2191 1 6 HELIX 4 4 GLN B 2192 GLY B 2194 5 3 SHEET 1 A 4 GLN A1002 ILE A1003 0 SHEET 2 A 4 THR B2196 ASN B2198 -1 O LEU B2197 N ILE A1003 SHEET 3 A 4 THR A1096 ASN A1098 -1 N THR A1096 O ASN B2198 SHEET 4 A 4 GLN B2102 ILE B2103 -1 O ILE B2103 N LEU A1097 SHEET 1 B 8 LYS A1043 GLY A1049 0 SHEET 2 B 8 GLY A1052 ILE A1066 -1 O ILE A1054 N ILE A1047 SHEET 3 B 8 HIS A1069 ILE A1077 -1 O ILE A1077 N ARG A1057 SHEET 4 B 8 VAL A1032 LEU A1033 1 N LEU A1033 O LEU A1076 SHEET 5 B 8 ILE A1084 ILE A1085 -1 O ILE A1084 N VAL A1032 SHEET 6 B 8 GLN A1018 ILE A1024 1 N LEU A1023 O ILE A1085 SHEET 7 B 8 LEU A1010 ILE A1015 -1 N ILE A1015 O GLN A1018 SHEET 8 B 8 GLY A1052 ILE A1066 -1 O GLU A1065 N LYS A1014 SHEET 1 C 8 LYS B2143 GLY B2149 0 SHEET 2 C 8 GLY B2152 ILE B2166 -1 O GLY B2152 N GLY B2149 SHEET 3 C 8 HIS B2169 ILE B2177 -1 O VAL B2175 N TYR B2159 SHEET 4 C 8 THR B2131 LEU B2133 1 N LEU B2133 O LEU B2176 SHEET 5 C 8 ILE B2184 ILE B2185 -1 O ILE B2184 N VAL B2132 SHEET 6 C 8 GLN B2118 ILE B2124 1 N LEU B2123 O ILE B2185 SHEET 7 C 8 LEU B2110 ILE B2115 -1 N ILE B2113 O LYS B2120 SHEET 8 C 8 GLY B2152 ILE B2166 -1 O GLU B2165 N LYS B2114 LINK N ASP A1030 C1 BAB2 A3500 1555 1555 1.65 SITE 1 AC1 3 ARG A1041 THR A1074 ASN A1088 SITE 1 AC2 4 ARG B2141 THR B2174 ASN B2188 HOH B5230 SITE 1 AC3 2 ARG A1008 LEU B2119 SITE 1 AC4 3 LEU A1019 LYS B2107 ARG B2108 SITE 1 AC5 1 TRP B2106 SITE 1 AC6 1 TRP A1006 SITE 1 AC7 1 LYS A1055 SITE 1 AC8 2 GLU B2121 HOH B5247 SITE 1 AC9 2 ARG B2141 GLN B2161 SITE 1 BC1 6 GLY A1048 AB2 A3500 HOH A5094 HOH A5156 SITE 2 BC1 6 ILE B2147 GLY B2148 SITE 1 BC2 3 AB2 A3500 ARG B2108 HOH B5243 SITE 1 BC3 35 ARG A1008 ASP A1025 GLY A1027 ALA A1028 SITE 2 BC3 35 ASP A1029 ASP A1030 ILE A1047 GLY A1048 SITE 3 BC3 35 GLY A1049 ILE A1050 PRO A1081 ILE A1084 SITE 4 BC3 35 BR A4011 BR A4012 HOH A5066 HOH A5094 SITE 5 BC3 35 HOH A5098 HOH A5122 HOH A5281 ARG B2108 SITE 6 BC3 35 ASP B2125 GLY B2127 ALA B2128 ASP B2129 SITE 7 BC3 35 ASP B2130 ILE B2147 GLY B2148 GLY B2149 SITE 8 BC3 35 ILE B2150 THR B2180 PRO B2181 ALA B2182 SITE 9 BC3 35 ILE B2184 HOH B5002 HOH B5038 CRYST1 86.610 86.610 33.660 90.00 90.00 90.00 P 43 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011546 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011546 0.000000 0.00000 SCALE3 0.000000 0.000000 0.029709 0.00000